Farzan F Bahin1,2, Khalid N Rasouli1, Karen Byth3,4, Luke F Hourigan5,6, Rajvinder Singh7, Gregor J Brown8,9, Simon A Zanati8,10, Alan Moss10, Spiro Raftopoulos11, Stephen J Williams1, Michael J Bourke1,2. 1. Department of Gastroenterology and Hepatology, Westmead Hospital, Sydney, Australia. 2. Westmead Clinical School, University of Sydney, Sydney, Australia. 3. Sydney Medical School NHMRC Clinical Trials Centre, University of Sydney, Sydney, Australia. 4. Research and Education Network, Westmead Hospital, Sydney, Australia. 5. Department of Gastroenterology and Hepatology, Princess Alexandra Hospital, Brisbane, Australia. 6. Greenslopes Private Hospital, Brisbane, Australia. 7. Department of Gastroenterology and Hepatology, Lyell McEwin Hospital, Adelaide, Australia. 8. Department of Gastroenterology and Hepatology, The Alfred Hospital, Melbourne, Australia. 9. Epworth Hospital, Richmond, Australia. 10. Department of Gastroenterology and Hepatology, Western Health, Melbourne, Australia. 11. Department of Gastroenterology and Hepatology, Sir Charles Gairdner Hospital, Perth, Australia.
Abstract
OBJECTIVES: Clinically significant bleeding (CSPEB) is the most frequent adverse event following wide-field endoscopic mucosal resection (WF-EMR) of large sessile and laterally spreading colorectal lesions (LSL). There is limited knowledge regarding accurate prediction of CSPEB. We aimed to derive a score to predict the risk of CSPEB. METHODS: Data on patient and lesion characteristics and outcomes from WF-EMRs of LSL ≥20 mm at 8 referral hospitals were analyzed. The cohort was divided at random into equal sized training and test groups. Independent predictors of CSPEB in the training cohort were identified by multiple logistic regression analysis and used to develop a risk score. The performance of this score was assessed in the independent test cohort. RESULTS: Over 80 months to June 2015, 2,128 patients with 2,424 LSL were referred for WF-EMR. Two thousand and twelve patients were eligible for analysis. There were 135 cases of CSPEB (6.7%). In the training cohort of 1,006 patients, the independent predictors of CSPEB were lesion size >30 mm (odds ratio (OR) 2.5), proximal colonic location (OR 2.3), presence of a major comorbidity (OR 1.5), and epinephrine in injection solution (OR 0.57). The derived risk score comprised lesion size >30 mm (2 points), proximal colon (2 points), presence of major comorbidity (1 point), and absence of epinephrine use (1 point). The probabilities of CSPEB for scores of 0, 1, 2, 3, 4, and ≥5 in the training cohort were 1.5, 2.0, 5.6, 7.8, 9.1, and 17.5% and were 0.9, 6.7, 4.9, 6.2, 9.0, and 15.7% in the test cohort. The probabilities of CSPEB in those with low (score 0-1), medium (score 2-4), and elevated (score 5-6) risk levels were 1.7, 7.1, and 17.5% in the training cohort and 3.4, 6.2, and 15.7% in the test cohort. CONCLUSIONS: Patients at elevated risk of CSPEB can be identified using four readily available variables. This knowledge may improve the management of those undergoing WF-EMR and assist in designing studies evaluating CSPEB.
OBJECTIVES: Clinically significant bleeding (CSPEB) is the most frequent adverse event following wide-field endoscopic mucosal resection (WF-EMR) of large sessile and laterally spreading colorectal lesions (LSL). There is limited knowledge regarding accurate prediction of CSPEB. We aimed to derive a score to predict the risk of CSPEB. METHODS: Data on patient and lesion characteristics and outcomes from WF-EMRs of LSL ≥20 mm at 8 referral hospitals were analyzed. The cohort was divided at random into equal sized training and test groups. Independent predictors of CSPEB in the training cohort were identified by multiple logistic regression analysis and used to develop a risk score. The performance of this score was assessed in the independent test cohort. RESULTS: Over 80 months to June 2015, 2,128 patients with 2,424 LSL were referred for WF-EMR. Two thousand and twelve patients were eligible for analysis. There were 135 cases of CSPEB (6.7%). In the training cohort of 1,006 patients, the independent predictors of CSPEB were lesion size >30 mm (odds ratio (OR) 2.5), proximal colonic location (OR 2.3), presence of a major comorbidity (OR 1.5), and epinephrine in injection solution (OR 0.57). The derived risk score comprised lesion size >30 mm (2 points), proximal colon (2 points), presence of major comorbidity (1 point), and absence of epinephrine use (1 point). The probabilities of CSPEB for scores of 0, 1, 2, 3, 4, and ≥5 in the training cohort were 1.5, 2.0, 5.6, 7.8, 9.1, and 17.5% and were 0.9, 6.7, 4.9, 6.2, 9.0, and 15.7% in the test cohort. The probabilities of CSPEB in those with low (score 0-1), medium (score 2-4), and elevated (score 5-6) risk levels were 1.7, 7.1, and 17.5% in the training cohort and 3.4, 6.2, and 15.7% in the test cohort. CONCLUSIONS:Patients at elevated risk of CSPEB can be identified using four readily available variables. This knowledge may improve the management of those undergoing WF-EMR and assist in designing studies evaluating CSPEB.
Authors: Michelle A Anderson; Tamir Ben-Menachem; S Ian Gan; Vasundhara Appalaneni; Subhas Banerjee; Brooks D Cash; Laurel Fisher; M Edwyn Harrison; Robert D Fanelli; Norio Fukami; Steven O Ikenberry; Rajeev Jain; Khalid Khan; Mary Lee Krinsky; David R Lichtenstein; John T Maple; Bo Shen; Laura Strohmeyer; Todd Baron; Jason A Dominitz Journal: Gastrointest Endosc Date: 2009-11-03 Impact factor: 9.427
Authors: Farzan F Bahin; Khalid N Rasouli; Stephen J Williams; Eric Y T Lee; Michael J Bourke Journal: Endoscopy Date: 2016-04-25 Impact factor: 10.093
Authors: Alan Moss; Michael J Bourke; Stephen J Williams; Luke F Hourigan; Gregor Brown; William Tam; Rajvinder Singh; Simon Zanati; Robert Y Chen; Karen Byth Journal: Gastroenterology Date: 2011-03-08 Impact factor: 22.682
Authors: Nicholas G Burgess; Andrew J Metz; Stephen J Williams; Rajvinder Singh; William Tam; Luke F Hourigan; Simon A Zanati; Gregor J Brown; Rebecca Sonson; Michael J Bourke Journal: Clin Gastroenterol Hepatol Date: 2013-10-01 Impact factor: 11.382
Authors: Crispin J Corte; Daniel C Burger; Gareth Horgan; Adam A Bailey; James E East Journal: United European Gastroenterol J Date: 2014-04 Impact factor: 4.623
Authors: Heiko Pohl; Ian S Grimm; Matthew T Moyer; Muhammad K Hasan; Douglas Pleskow; B Joseph Elmunzer; Mouen A Khashab; Omid Sanaei; Firas H Al-Kawas; Stuart R Gordon; Abraham Mathew; John M Levenick; Harry R Aslanian; Fadi Antaki; Daniel von Renteln; Seth D Crockett; Amit Rastogi; Jeffrey A Gill; Ryan J Law; Pooja A Elias; Maria Pellise; Michael B Wallace; Todd A Mackenzie; Douglas K Rex Journal: Gastroenterology Date: 2019-03-15 Impact factor: 22.682
Authors: Douglas K Rex; C Richard Boland; Jason A Dominitz; Francis M Giardiello; David A Johnson; Tonya Kaltenbach; Theodore R Levin; David Lieberman; Douglas J Robertson Journal: Am J Gastroenterol Date: 2017-06-06 Impact factor: 10.864
Authors: Pujan Kandel; Murtaza Hussain; Deepesh Yadav; Santosh K Dhungana; Bhaumik Brahmbhatt; Massimo Raimondo; Frank J Lukens; Ghassan Bachuwa; Michael B Wallace Journal: Endosc Int Open Date: 2022-10-17
Authors: Tiing Leong Ang; Jit Fong Lim; Tju Siang Chua; Kok Yang Tan; James Weiquan Li; Chern Hao Chong; Kok Ann Gwee; Vikneswaran S/O Namasivayam; Charles Kien Fong Vu; Christopher Jen Lock Khor; Lai Mun Wang; Khay Guan Yeoh Journal: Singapore Med J Date: 2020-07-16 Impact factor: 3.331
Authors: Kirles Bishay; Zhao Wu Meng; Levi Frehlich; Matthew T James; Gilaad G Kaplan; Michael J Bourke; Robert J Hilsden; Steven J Heitman; Nauzer Forbes Journal: Surg Endosc Date: 2021-03-09 Impact factor: 4.584